Registrations are now open for Beckman Coulter Life Sciences’ 2022 SPRI Grants for Genomic Research program, the company announced this week.
With a focus on providing streamlined genomic workflow solutions to support the next generation of researchers, the company will award up to eight grants this year.
The grants will consist of $3,000 USD (or local currency equivalent) in genomics catalog products from Beckman Coulter Life Sciences.
Applications will be accepted now through Dec. 15, 2022.
The entry form and a complete list of rules can be found at https://www.beckman.com/reagents/genomic/collaboration-grant-program/spri-grants.
Grant program research areas include nucleic acid extraction, liquid biopsy, long-read sequencing and genomics applications. Winners will be evaluated based on criteria including research objective, genomic reagent request and how the product would be used in the field of research.
“We strive to be a trusted partner of the research process to accelerate answers toward the next big breakthrough moment,” said Amy Yoder, director of genomics product management at Beckman Coulter Life Sciences. “These grants represent just part of how we continuously invest in the scientific community at every level to fuel creativity that can lead to advancements. We’re proud to be a part of the journey of researchers and are eager to review submissions.”
The grant program has enabled previous winners to research a novel cystic fibrosis treatment, new cancer molecular diagnostic tools, and novel models to study diabetes and metabolism.
Beckman Coulter Life Sciences offers additional opportunities and support for the scientific community by sponsoring the iGEM Competition and the Beckman Coulter Life Sciences Genomic Solutions Collaboration Program.